Explore the full directors' dealings record of Alaunos Therapeutics, Inc., a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Alaunos Therapeutics, Inc. has logged 9 insider filings. Market capitalisation: €6.2m. The latest transaction was disclosed on 24 June 2022 — Attribution. Among the most active insiders: Huang James. Every trade is free.